Malaria in endemic areas.
Omari
Aika
A
Liverpool School of Tropical Medicine, Liverpool, UK.
Garner
Paul
P
D000962:Antimalarials / Q000627:therapeutic use; D000077549:Artemether; D037621:Artemisinins / Q000627:therapeutic use; D001803:Blood Transfusion; D002738:Chloroquine / Q000627:therapeutic use; D003676:Deferoxamine / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D016778:Malaria, Falciparum / Q000188:drug therapy; D011739:Pyrimethamine / Q000627:therapeutic use; D011803:Quinine / Q000008:administration & dosage / Q000627:therapeutic use; D012717:Sesquiterpenes / Q000627:therapeutic use; D013413:Sulfadoxine / Q000627:therapeutic use
D000962:Antimalarials; D037621:Artemisinins; D004338:Drug Combinations; D012717:Sesquiterpenes; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D002738:Chloroquine; C031327:artemisinin; D011803:Quinine; D000077549:Artemether; D003676:Deferoxamine; D011739:Pyrimethamine